TA53 Diabetes (types 1 and 2) - long acting insulin analogues: guidance
This document shows the full guidance on the use of long-acting insulin analogues for the treatment of diabetes.
|
TA53 Diabetes (types 1 and 2) - long acting insulin analogues: guidance
06 December 2002 (132 Kb 38 sec) |
